Orlando-based company Hesperos was founded in 2015 and now is focused on creating the custom organ-on-a-chip systems, according to the specific research requirements. They raised a total $5.9M through multiple grants from National Institutes of Health (NIH) and National Center for Advancing Translational Sciences (NCATS).
The company’s organs-on-chips are designed to assess efficacy and toxicity profiles of the tested drugs, while using low volumes and amounts of materials. The maintenance in the serum-free media also mimics the blood circulation, according to Hesperos.